Abstract

The objective of this contract is for Immunex to generate the necessary number of 50L fermentation-scale, GMP production runs that result in clinical grade product for NIAID/NIH to use to continue with clinical research of the yeast-produced malaria vaccine.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy And Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AO052710-001
Application #
2298194
Study Section
Project Start
1995-09-29
Project End
1997-09-28
Budget Start
1996-09-29
Budget End
1997-09-28
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Immunex Corporation
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98101